Therefore, KLF2 and KLF4 are upregulated in CCM lesions and in KRIT1, CCM2 or CCM3 deficient endothelial cells, and their downregulation can reverse CCM disease phenotypes. This evidence concerns the gene KRIT1 and cerebral cavernous malformation.